Literature DB >> 9494827

Influenza.

N J Cox1, K Fukuda.   

Abstract

Influenza viruses are unique in their ability to cause recurrent epidemics and truly global pandemics during which acute febrile respiratory disease occurs explosively in all age groups. Epidemics of varying severity occur almost annually in temperate climates and are punctuated by the much less frequent but more dramatic occurrence of pandemic influenza. Increases in hospitalization and death often accompany widespread morbidity during influenza epidemics and pandemics. Influenza pandemics also threaten to disrupt other essential and nonessential services through high absenteeism, with high economic losses resulting. The medical impact and disruptive effects of epidemics and pandemics clearly justify careful global monitoring of influenza and strenuous efforts to prevent this emerging and reemerging disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9494827     DOI: 10.1016/s0891-5520(05)70406-2

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  17 in total

Review 1.  Influenza.

Authors:  Tom Jefferson
Journal:  BMJ Clin Evid       Date:  2009-03-12

Review 2.  Influenza.

Authors:  Eliana Ferroni; Tom Jefferson
Journal:  BMJ Clin Evid       Date:  2011-10-21

3.  Inhibition of human immunodeficiency virus type 1 replication prior to reverse transcription by influenza virus stimulation.

Authors:  L A Pinto; V Blazevic; B K Patterson; C Mac Trubey; M J Dolan; G M Shearer
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 4.  Current research on influenza and other respiratory viruses: II international symposium.

Authors:  F M Munoz; G J Galasso; J M Gwaltney; F G Hayden; B Murphy; R Webster; P Wright; R B Couch
Journal:  Antiviral Res       Date:  2000-05       Impact factor: 5.970

Review 5.  Influenza vaccination and antiviral therapy: is there a role for concurrent administration in the institutionalised elderly?

Authors:  Paul J Drinka
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

6.  Medical care capacity for influenza outbreaks, Los Angeles.

Authors:  Carol A Glaser; Sabrina Gilliam; William W Thompson; David E Dassey; Stephen H Waterman; Mitchell Saruwatari; Stanley Shapiro; Keiji Fukuda
Journal:  Emerg Infect Dis       Date:  2002-06       Impact factor: 6.883

7.  Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice.

Authors:  Arash Shahangian; Edward K Chow; Xiaoli Tian; Jason R Kang; Amir Ghaffari; Su Y Liu; John A Belperio; Genhong Cheng; Jane C Deng
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

8.  Type I interferon induction during influenza virus infection increases susceptibility to secondary Streptococcus pneumoniae infection by negative regulation of γδ T cells.

Authors:  Wenjing Li; Bruno Moltedo; Thomas M Moran
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

9.  Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China 1999.

Authors:  Timothy M Uyeki; Yu-Hoi Chong; Jacqueline M Katz; Wilina Lim; Yuk-Yin Ho; Sophia S Wang; Thomas H F Tsang; Winnie Wan-Yee Au; Shuk-Chi Chan; Thomas Rowe; Jean Hu-Primmer; Jensa C Bell; William W Thompson; Carolyn Buxton Bridges; Nancy J Cox; Kwok-Hang Mak; Keiji Fukuda
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

10.  Review of an influenza surveillance system, Beijing, People's Republic of China.

Authors:  Peng Yang; Wei Duan; Min Lv; Weixian Shi; Xiaoming Peng; Xiaomei Wang; Yanning Lu; Huijie Liang; Holly Seale; Xinghuo Pang; Quanyi Wang
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.